Novartis (Miochol) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 1

Novartis (Miochol) General Information

Description

An inject-able miotic pharmaceutical drug. The asset is used during certain eye surgeries to constrict the pupil.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Corporate Office
  • Global Eye Health Center
  • 1400 North Goodman Street
  • Rochester, NY 14609
  • United States
Primary Industry
Buildings and Property
Other Industries
Pharmaceuticals
Acquirer
Bausch + Lomb
Corporate Office
  • Global Eye Health Center
  • 1400 North Goodman Street
  • Rochester, NY 14609
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Novartis (Miochol) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Novartis (Miochol)‘s full profile, request access.

Request a free trial

Novartis (Miochol) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Novartis (Miochol)‘s full profile, request access.

Request a free trial

Novartis (Miochol) FAQs

  • Where is Novartis (Miochol) headquartered?

    Novartis (Miochol) is headquartered in Rochester, NY.

  • What industry is Novartis (Miochol) in?

    Novartis (Miochol)’s primary industry is Buildings and Property.

  • Is Novartis (Miochol) a private or public company?

    Novartis (Miochol) is a Private company.

  • What is Novartis (Miochol)’s current revenue?

    The current revenue for Novartis (Miochol) is .

  • Who are Novartis (Miochol)’s investors?

    Novartis has invested in Novartis (Miochol).

  • When was Novartis (Miochol) acquired?

    Novartis (Miochol) was acquired on 13-Sep-2010.

  • Who acquired Novartis (Miochol)?

    Novartis (Miochol) was acquired by Bausch + Lomb.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »